2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.
about
2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@en
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@nl
type
label
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@en
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@nl
prefLabel
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@en
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
2-Deoxyglucose and sorafenib s ...... epatocellular carcinoma cells.
@en
P2093
Fuminobu Shinozaki
Minoru Tomizawa
Naoki Ishige
Shigenori Yamamoto
Takao Sugiyama
Yasufumi Motoyoshi
P2860
P304
P356
10.3892/OL.2016.5510
P577
2016-12-16T00:00:00Z